| Type |
Details |
Score |
| HT Sample |
| Organism Name: |
mouse, laboratory |
|
|
|
|
| Notes: |
extra copy of the Dyrk1A gene |
| Curation Status: |
Not curated (Transgenic sample) |
|
•
•
•
•
•
|
| HT Sample |
| Organism Name: |
mouse, laboratory |
|
|
|
|
| Notes: |
extra copy of the Dyrk1A gene |
| Curation Status: |
Not curated (Transgenic sample) |
|
•
•
•
•
•
|
| HT Sample |
| Organism Name: |
mouse, laboratory |
|
|
|
|
| Notes: |
extra copy of the Dyrk1A gene |
| Curation Status: |
Not curated (Transgenic sample) |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Stoler-Barak L |
| Year: |
2023 |
| Journal: |
Nat Commun |
| Title: |
B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation. |
| Volume: |
14 |
| Issue: |
1 |
| Pages: |
1462 |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Pons-Espinal M |
| Year: |
2013 |
| Journal: |
Neurobiol Dis |
| Title: |
Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A. |
| Volume: |
60 |
|
| Pages: |
18-31 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lu S |
| Year: |
2016 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
Overexpression of Dyrk1A regulates cardiac troponin T splicing in cells and mice. |
| Volume: |
473 |
| Issue: |
4 |
| Pages: |
993-998 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
GarcĂa-Cerro S |
| Year: |
2018 |
| Journal: |
Neurobiol Dis |
| Title: |
Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene. |
| Volume: |
110 |
|
| Pages: |
206-217 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lee HJ |
| Year: |
2020 |
| Journal: |
Free Radic Biol Med |
| Title: |
The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation. |
| Volume: |
160 |
|
| Pages: |
575-595 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Alvarez M |
| Year: |
2007 |
| Journal: |
Mol Biol Cell |
| Title: |
DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding. |
| Volume: |
18 |
| Issue: |
4 |
| Pages: |
1167-78 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Park J |
| Year: |
2012 |
| Journal: |
J Cell Sci |
| Title: |
Dyrk1A negatively regulates the actin cytoskeleton through threonine phosphorylation of N-WASP. |
| Volume: |
125 |
| Issue: |
Pt 1 |
| Pages: |
67-80 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hijazi M |
| Year: |
2013 |
| Journal: |
Exp Neurol |
| Title: |
Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome. |
| Volume: |
239 |
|
| Pages: |
229-34 |
|
•
•
•
•
•
|
| Transgene |
| Type: |
transgene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:6506451 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2021-02-16 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1608916 |
| Pattern: |
Regionally restricted |
| Stage: |
TS16 |
| Assay Id: |
MGI:6506463 |
| Age: |
embryonic day 10.0 |
|
| Note: |
Expression pattern similar to that of Dyrk1a in proliferative regious surrounding ventricles |
| Specimen Label: |
1A Dscr1 E10 |
| Detected: |
true |
| Specimen Num: |
1 |
|
•
•
•
•
•
|
| Interaction Experiment |
| Description: |
Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4. |
|
•
•
•
•
•
|
| Interaction Experiment |
| Description: |
DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. |
|
•
•
•
•
•
|
| Interaction Experiment |
| Description: |
DYRK1a mediates BAFF-induced noncanonical NF-?B activation to promote autoimmunity and B-cell leukemogenesis. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kim D |
| Year: |
2004 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
Regulation of Dyrk1A kinase activity by 14-3-3. |
| Volume: |
323 |
| Issue: |
2 |
| Pages: |
499-504 |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
41
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
This entry includes PHYHIP and PHYHIPL from humans. PHYHIP interacts with DYRK1A and may contribute to new cellular functions of DYRK1A []. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Park J |
| Year: |
2013 |
| Journal: |
Exp Neurobiol |
| Title: |
New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down Syndrome. |
| Volume: |
22 |
| Issue: |
4 |
| Pages: |
244-8 |
|
•
•
•
•
•
|
| Allele |
| Name: |
dual-specificity tyrosine phosphorylation regulated kinase 1a; targeted mutation 1, Shanghai Model Organisms Center |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
dual-specificity tyrosine phosphorylation regulated kinase 1a; endonuclease-mediated mutation 1, Kazuhiro Yamakawa |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Song WJ |
| Year: |
2013 |
| Journal: |
Neurosci Lett |
| Title: |
Dyrk1A-mediated phosphorylation of RCAN1 promotes the formation of insoluble RCAN1 aggregates. |
| Volume: |
554 |
|
| Pages: |
135-40 |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Dyrk1a/Dyrk1a<+> |
| Background: |
C57BL/6J-Dyrk1a |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bescond M |
| Year: |
2005 |
| Journal: |
Int J Biochem Cell Biol |
| Title: |
Dual-specificity tyrosine-phosphorylated and regulated kinase 1A (DYRK1A) interacts with the phytanoyl-CoA alpha-hydroxylase associated protein 1 (PAHX-AP1), a brain specific protein. |
| Volume: |
37 |
| Issue: |
4 |
| Pages: |
775-83 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Souchet B |
| Year: |
2019 |
| Journal: |
Sci Rep |
| Title: |
Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models. |
| Volume: |
9 |
| Issue: |
1 |
| Pages: |
3914 |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion JF4, GENSAT Project at Rockefeller University |
| Allele Type: |
Transgenic |
| Attribute String: |
Reporter |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, targeted mutation, mutant strain |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) () phosphorylates serine, threonine and tyrosine residues in proteins such as CRY2, FOXO1 and SIRT1 [, , , ]. It can be activated by tyrosine autophosphorylation [, ]. DYRK1A play a role in a signaling pathway regulating nuclear functions of cell proliferation. DYRK1A is a neurogenesis regulator and plays an important role in altered brain development in Down syndrome [, ]. Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DYRK1B also known as Mirk) also phosphorylates serine, threonine and tyrosine residues, and has been shown to enhance the transcriptional activity of HNF1A and FOXO1 []. Mirk is reported to be an inhibitor of epithelial cell migration [], and appears to mediate carcinoma cell survival in specific environments [].This entry also includes mnb from Drosophila melanogaster. It plays a role in the specific control of proper proliferation of optic lobe neuronal progeny [].This entry represents the catalytic domain found in DYRK1A and DYRK1B. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shindoh N |
| Year: |
1996 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
Cloning of a human homolog of the Drosophila minibrain/rat Dyrk gene from "the Down syndrome critical region" of chromosome 21. |
| Volume: |
225 |
| Issue: |
1 |
| Pages: |
92-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tejedor FJ |
| Year: |
2011 |
| Journal: |
FEBS J |
| Title: |
MNB/DYRK1A as a multiple regulator of neuronal development. |
| Volume: |
278 |
| Issue: |
2 |
| Pages: |
223-35 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Park J |
| Year: |
2009 |
| Journal: |
Cell Mol Life Sci |
| Title: |
Function and regulation of Dyrk1A: towards understanding Down syndrome. |
| Volume: |
66 |
| Issue: |
20 |
| Pages: |
3235-40 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Walte A |
| Year: |
2013 |
| Journal: |
FEBS J |
| Title: |
Mechanism of dual specificity kinase activity of DYRK1A. |
| Volume: |
280 |
| Issue: |
18 |
| Pages: |
4495-511 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kentrup H |
| Year: |
1996 |
| Journal: |
J Biol Chem |
| Title: |
Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. |
| Volume: |
271 |
| Issue: |
7 |
| Pages: |
3488-95 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hong SH |
| Year: |
2012 |
| Journal: |
PLoS Genet |
| Title: |
Minibrain/Dyrk1a regulates food intake through the Sir2-FOXO-sNPF/NPY pathway in Drosophila and mammals. |
| Volume: |
8 |
| Issue: |
8 |
| Pages: |
e1002857 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lim S |
| Year: |
2002 |
| Journal: |
J Biol Chem |
| Title: |
Mirk protein kinase is activated by MKK3 and functions as a transcriptional activator of HNF1alpha. |
| Volume: |
277 |
| Issue: |
28 |
| Pages: |
25040-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zou Y |
| Year: |
2003 |
| Journal: |
J Biol Chem |
| Title: |
Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M. |
| Volume: |
278 |
| Issue: |
49 |
| Pages: |
49573-81 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lee K |
| Year: |
2000 |
| Journal: |
Cancer Res |
| Title: |
Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells. |
| Volume: |
60 |
| Issue: |
13 |
| Pages: |
3631-7 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant stock, transgenic |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 189N3, Yann Herault |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
110
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) () phosphorylates serine, threonine and tyrosine residues in proteins such as CRY2, FOXO1 and SIRT1 [, , , ]. It can be activated by tyrosine autophosphorylation [, ]. DYRK1A play a role in a signaling pathway regulating nuclear functions of cell proliferation. DYRK1A is a neurogenesis regulator and plays an important role in altered brain development in Down syndrome [, ]. Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DYRK1B also known as Mirk) also phosphorylates serine, threonine and tyrosine residues, and has been shown to enhance the transcriptional activity of HNF1A and FOXO1 []. Mirk is reported to be an inhibitor of epithelial cell migration [], and appears to mediate carcinoma cell survival in specific environments [].This entry also includes mnb from Drosophila melanogaster. It plays a role in the specific control of proper proliferation of optic lobe neuronal progeny []. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nguyen TL |
| Year: |
2018 |
| Journal: |
Dis Model Mech |
| Title: |
Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A. |
| Volume: |
11 |
| Issue: |
9 |
|
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 12, Edward M Rubin |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
transgenic, congenic, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
transgenic, mutant strain, congenic |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(DYRK1A)36Wjs/? |
| Background: |
involves: C57BL/6NCrjBgi |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(Dyrk1a)189N3Yah/? |
| Background: |
B6.129P2-Tg(Dyrk1a)189N3Yah/Yah |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
transgenic, mutant strain, congenic |
|
•
•
•
•
•
|
| Allele |
| Name: |
deletion, Chr 16, Y Eugene Yu 14 |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(CEPHY152F7)12Hgc/? |
| Background: |
(C57BL/6 x FVB/N)F1 |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(CEPHY152F7)12Hgc/? |
| Background: |
FVB-Tg(CEPHY152F7)12Hgc |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
181
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
329
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, congenic, chromosome aberration |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Del(16Dyrk1a-Kcnj6)14Yey/+ |
| Background: |
B6.129S7-Del(16Dyrk1a-Kcnj6)14Yey |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Leder S |
| Year: |
1999 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
Cloning and characterization of DYRK1B, a novel member of the DYRK family of protein kinases. |
| Volume: |
254 |
| Issue: |
2 |
| Pages: |
474-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Schneider P |
| Year: |
2015 |
| Journal: |
Nat Commun |
| Title: |
Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1. |
| Volume: |
6 |
|
| Pages: |
8023 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sheppard O |
| Year: |
2012 |
| Journal: |
Neurobiol Aging |
| Title: |
Altered regulation of tau phosphorylation in a mouse model of down syndrome aging. |
| Volume: |
33 |
| Issue: |
4 |
| Pages: |
828.e31-44 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lee P |
| Year: |
2016 |
| Journal: |
Leukemia |
| Title: |
The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome. |
| Volume: |
30 |
| Issue: |
9 |
| Pages: |
1816-23 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
629
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
763
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
725
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
593
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
763
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
523
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
754
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
chromosome aberration, congenic, deletion, duplication, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
deletion, congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Del(16Dyrk1a-Kcnj6)14Yey/? Dp(16Lipi-Zbtb21)1Yey/? |
| Background: |
B6.129S7-Del(16Dyrk1a-Kcnj6)14Yey/Dp(16Lipi-Zbtb21)1Yey |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Forristal C |
| Year: |
2014 |
| Journal: |
Mol Cell Biol |
| Title: |
Loss of the mammalian DREAM complex deregulates chondrocyte proliferation. |
| Volume: |
34 |
| Issue: |
12 |
| Pages: |
2221-34 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Deitz SL |
| Year: |
2011 |
| Journal: |
Genetics |
| Title: |
Trisomic and allelic differences influence phenotypic variability during development of Down syndrome mice. |
| Volume: |
189 |
| Issue: |
4 |
| Pages: |
1487-95 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kim J |
| Year: |
2016 |
| Journal: |
Cancer Res |
| Title: |
Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways. |
| Volume: |
76 |
| Issue: |
21 |
| Pages: |
6424-6435 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jamal R |
| Year: |
2022 |
| Journal: |
PLoS One |
| Title: |
Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models. |
| Volume: |
17 |
| Issue: |
2 |
| Pages: |
e0264254 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Navarro-Romero A |
| Year: |
2019 |
| Journal: |
Neurobiol Dis |
| Title: |
Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome. |
| Volume: |
125 |
|
| Pages: |
92-106 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Siddiqui A |
| Year: |
2008 |
| Journal: |
Genes Brain Behav |
| Title: |
Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801. |
| Volume: |
7 |
| Issue: |
7 |
| Pages: |
810-20 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Thomazeau A |
| Year: |
2023 |
| Journal: |
Front Neurosci |
| Title: |
Glutamatergic synaptic deficits in the prefrontal cortex of the Ts65Dn mouse model for Down syndrome. |
| Volume: |
17 |
|
| Pages: |
1171797 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Illouz T |
| Year: |
2021 |
| Journal: |
Commun Biol |
| Title: |
Maternal antibodies facilitate Amyloid-β clearance by activating Fc-receptor-Syk-mediated phagocytosis. |
| Volume: |
4 |
| Issue: |
1 |
| Pages: |
329 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lee HJ |
| Year: |
2023 |
| Journal: |
Pharmacol Res |
| Title: |
Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling. |
| Volume: |
190 |
|
| Pages: |
106725 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kim J |
| Year: |
2022 |
| Journal: |
Front Immunol |
| Title: |
Inhibiting EGFR/HER-2 ameliorates neuroinflammatory responses and the early stage of tau pathology through DYRK1A. |
| Volume: |
13 |
|
| Pages: |
903309 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ortega M |
| Year: |
2022 |
| Journal: |
Front Mol Neurosci |
| Title: |
Proteomic profiling reveals mitochondrial dysfunction in the cerebellum of transgenic mice overexpressing DYRK1A, a Down syndrome candidate gene. |
| Volume: |
15 |
|
| Pages: |
1015220 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Trovò L |
| Year: |
2020 |
| Journal: |
Neurobiol Dis |
| Title: |
The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo. |
| Volume: |
138 |
|
| Pages: |
104791 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
SengĂĽl GF |
| Year: |
2024 |
| Journal: |
Biochim Biophys Acta Mol Cell Res |
| Title: |
Hsc70 phosphorylation patterns and calmodulin regulate AP2 Clathrin-Coated-Vesicle life span for cell adhesion protein transport. |
| Volume: |
1871 |
| Issue: |
1 |
| Pages: |
119611 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rachidi M |
| Year: |
2007 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
New cerebellar phenotypes in YAC transgenic mouse in vivo library of human Down syndrome critical region-1. |
| Volume: |
364 |
| Issue: |
3 |
| Pages: |
488-94 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Egusa H |
| Year: |
2011 |
| Journal: |
Bone |
| Title: |
The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells. |
| Volume: |
49 |
| Issue: |
2 |
| Pages: |
264-74 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Weiss CS |
| Year: |
2013 |
| Journal: |
PLoS One |
| Title: |
DYRK2 negatively regulates cardiomyocyte growth by mediating repressor function of GSK-3β on eIF2Bε. |
| Volume: |
8 |
| Issue: |
9 |
| Pages: |
e70848 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
330
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
375
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
88
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
330
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
330
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
212
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gupta M |
| Year: |
2016 |
| Journal: |
Mamm Genome |
| Title: |
Mouse models of Down syndrome: gene content and consequences. |
| Volume: |
27 |
| Issue: |
11-12 |
| Pages: |
538-555 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Smith DJ |
| Year: |
1995 |
| Journal: |
Genomics |
| Title: |
Construction of a panel of transgenic mice containing a contiguous 2-Mb set of YAC/P1 clones from human chromosome 21q22.2. |
| Volume: |
27 |
| Issue: |
3 |
| Pages: |
425-34 |
|
•
•
•
•
•
|